The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations

Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

• A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes
• Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.
• An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters
• An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.
• An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.
• A detailed demand and supply assessment of geographies in this domain.
• An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.
• A discussion on the potential growth areas in this domain.
• A review of the landscape of prefilled syringe manufacturers.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

• Scale of Operation

• Preclinical / Clinical
• Commercial

• Type of Drug Molecule

• Biologic
• Small Molecule

• Target Therapeutic Area

• Blood Disorders
• Infectious Diseases
• Metabolic Disorders
• Oncological Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

• Syringe Barrel Material

• Glass
• Plastic

• Number of Barrel Chambers

• Single Chamber
• Dual Chamber

• Key Geographical Region
• North America
• Europe
• Latin America
• Asia-Pacific
• Middle East and Africa

Key companies covered in the report

• Ajinomoto Bio-Pharma Services
• AMRI
• BioPharma Solutions
• Emergent BioSolutions
• Patheon
• Consort Medical
• EVER Pharma
• GlaxoSmithKline
• IDT Biologika
• Rentschler Biopharma
• Siegfried
• Vetter Pharma
• Biocon
• Intas Pharmaceuticals
• Kemwell Biopharma
• Square Pharmaceuticals

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

Other Recent Offerings

1. Prefilled Syringes Market (5th Edition), 2020-2030
2. Biologics Fill / Finish Services Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Related Post
The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis
Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis
The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis
The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis
The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

Contact Information:

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis